Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_assertion type Assertion NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_head.
- NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_assertion description "[Retinoic acid receptor beta 2 (RARbeta2) isoform has been considered a putative tumor suppressor because it is expressed in normal cells but is lacking in most tumors, including breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_provenance.
- NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_assertion evidence source_evidence_literature NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_provenance.
- NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_assertion SIO_000772 19275755 NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_provenance.
- NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_assertion wasDerivedFrom befree-20150227 NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_provenance.
- NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_assertion wasGeneratedBy ECO_0000203 NP665747.RASDjKi9lOQBS2H6RNX3cJj4H4lmHmzqAT6k8ugLPAP6c130_provenance.